Alpha Tau Medical (DRTS) Competitors $2.98 -0.09 (-2.93%) Closing price 08/1/2025 03:59 PM EasternExtended Trading$2.98 0.00 (0.00%) As of 08/1/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock DRTS vs. PLSE, MDXG, INMD, KMTS, SIBN, IRMD, EMBC, BBNX, AXGN, and AVNSShould you be buying Alpha Tau Medical stock or one of its competitors? The main competitors of Alpha Tau Medical include Pulse Biosciences (PLSE), MiMedx Group (MDXG), InMode (INMD), Kestra Medical Technologies (KMTS), SiBone (SIBN), iRadimed (IRMD), Embecta (EMBC), Beta Bionics (BBNX), AxoGen (AXGN), and Avanos Medical (AVNS). These companies are all part of the "medical equipment" industry. Alpha Tau Medical vs. Its Competitors Pulse Biosciences MiMedx Group InMode Kestra Medical Technologies SiBone iRadimed Embecta Beta Bionics AxoGen Avanos Medical Pulse Biosciences (NASDAQ:PLSE) and Alpha Tau Medical (NASDAQ:DRTS) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, analyst recommendations, risk, dividends, media sentiment and valuation. Do analysts prefer PLSE or DRTS? Pulse Biosciences currently has a consensus target price of $22.00, indicating a potential upside of 49.15%. Alpha Tau Medical has a consensus target price of $8.00, indicating a potential upside of 168.46%. Given Alpha Tau Medical's higher probable upside, analysts clearly believe Alpha Tau Medical is more favorable than Pulse Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Pulse Biosciences 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Alpha Tau Medical 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has higher valuation & earnings, PLSE or DRTS? Alpha Tau Medical has lower revenue, but higher earnings than Pulse Biosciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPulse Biosciences$700K1,417.48-$53.58MN/AN/AAlpha Tau MedicalN/AN/A-$31.75M-$0.46-6.48 Which has more volatility & risk, PLSE or DRTS? Pulse Biosciences has a beta of 1.6, indicating that its share price is 60% more volatile than the S&P 500. Comparatively, Alpha Tau Medical has a beta of 0.99, indicating that its share price is 1% less volatile than the S&P 500. Is PLSE or DRTS more profitable? Alpha Tau Medical's return on equity of -49.48% beat Pulse Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Pulse BiosciencesN/A -68.44% -58.17% Alpha Tau Medical N/A -49.48%-36.69% Does the media prefer PLSE or DRTS? In the previous week, Pulse Biosciences had 3 more articles in the media than Alpha Tau Medical. MarketBeat recorded 3 mentions for Pulse Biosciences and 0 mentions for Alpha Tau Medical. Pulse Biosciences' average media sentiment score of 0.50 beat Alpha Tau Medical's score of 0.00 indicating that Pulse Biosciences is being referred to more favorably in the media. Company Overall Sentiment Pulse Biosciences Positive Alpha Tau Medical Neutral Do institutionals & insiders believe in PLSE or DRTS? 77.0% of Pulse Biosciences shares are held by institutional investors. Comparatively, 2.7% of Alpha Tau Medical shares are held by institutional investors. 71.5% of Pulse Biosciences shares are held by company insiders. Comparatively, 39.5% of Alpha Tau Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. SummaryPulse Biosciences beats Alpha Tau Medical on 6 of the 11 factors compared between the two stocks. Get Alpha Tau Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for DRTS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DRTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DRTS vs. The Competition Export to ExcelMetricAlpha Tau MedicalMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$260.40M$6.76B$5.49B$9.52BDividend YieldN/A1.32%4.73%4.09%P/E Ratio-6.4820.9428.7823.81Price / SalesN/A54.12372.2066.04Price / CashN/A20.5035.4557.96Price / Book3.354.468.275.54Net Income-$31.75M$174.54M$3.25B$259.28M7 Day Performance-2.61%-5.27%-3.70%-4.64%1 Month Performance-5.99%-3.94%4.34%4.41%1 Year Performance41.23%8.26%25.90%17.95% Alpha Tau Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DRTSAlpha Tau Medical2.1218 of 5 stars$2.98-2.9%$8.00+168.5%+43.3%$260.40MN/A-6.4880Positive NewsPLSEPulse Biosciences3.9326 of 5 stars$15.21+1.9%$22.00+44.6%-2.3%$1.00B$700K0.00140News CoveragePositive NewsMDXGMiMedx Group3.1093 of 5 stars$6.79+0.3%$11.50+69.4%+7.2%$999.94M$352.38M25.15870Trending NewsEarnings ReportAnalyst ForecastAnalyst RevisionINMDInMode3.1262 of 5 stars$14.54-1.2%$18.54+27.5%-17.1%$930.44M$394.82M6.24480News CoverageEarnings ReportAnalyst ForecastKMTSKestra Medical Technologies0.9976 of 5 stars$16.50-0.3%$27.33+65.7%N/A$849.82M$59.81M0.00300Positive NewsSIBNSiBone3.7055 of 5 stars$17.60+2.0%$22.50+27.8%+17.2%$735.10M$167.18M-27.50350Positive NewsUpcoming EarningsIRMDiRadimed4.1846 of 5 stars$57.11+1.4%$72.00+26.1%+43.4%$716.11M$73.24M36.85110Trending NewsDividend AnnouncementGap UpEMBCEmbecta4.6458 of 5 stars$11.33-3.4%$19.00+67.7%-35.3%$685.53M$1.12B12.592,100News CoverageUpcoming EarningsBBNXBeta Bionics2.3503 of 5 stars$13.99-5.7%$23.44+67.6%N/A$643.40M$69.83M0.00294Trending NewsEarnings ReportAnalyst ForecastLockup ExpirationAnalyst RevisionAXGNAxoGen2.3724 of 5 stars$12.99-2.8%$24.50+88.6%+55.3%$608.92M$187.34M-86.59450Upcoming EarningsHigh Trading VolumeAVNSAvanos Medical2.3333 of 5 stars$12.02+0.1%N/A-53.7%$555.39M$687.80M-1.442,227News CoverageUpcoming Earnings Related Companies and Tools Related Companies PLSE Alternatives MDXG Alternatives INMD Alternatives KMTS Alternatives SIBN Alternatives IRMD Alternatives EMBC Alternatives BBNX Alternatives AXGN Alternatives AVNS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DRTS) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredToo busy to trade? Good.Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alpha Tau Medical Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alpha Tau Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.